Reid M S, Tafti M, Geary J N, Nishino S, Siegel J M, Dement W C, Mignot E
Stanford University Sleep Disorders Research Center, Palo Alto, CA 94304.
Neuroscience. 1994 Apr;59(3):511-22. doi: 10.1016/0306-4522(94)90173-2.
Cataplexy in the narcoleptic canine has been shown to increase after systemic administration of cholinergic agonists. Furthermore, the number of cholinergic receptors in the pontine reticular formation of narcoleptic canines is significantly elevated. In the present study we have investigated the effects of cholinergic drugs administered directly into the pontine reticular formation on cataplexy, as defined by brief episodes of hypotonia induced by emotions, in narcoleptic canines. Carbachol and atropine were perfused through microdialysis probes implanted bilaterally in the pontine reticular formation of freely moving, narcoleptic and control Doberman pinschers. Cataplexy was quantified using the Food-Elicited Cataplexy Test, and analysed using recordings of electroencephalogram, electrooculogram and electromyogram. Cataplexy was characterized by a desynchronized electroencephalogram and a drop in electromyogram and electrooculogram activity. In narcoleptic canines, both unilateral and bilateral carbachol (10(-5) to 10(-3) M) produced a dose-dependent increase in cataplexy, which resulted in complete muscle tone suppression at the highest concentration. In control canines, neither bilateral nor unilateral carbachol (10(-5) to 10(-3) M) produced cataplexy, although bilateral carbachol, did produce muscle atonia at the highest dose (10(-3)). The increase in cataplexy after bilateral carbachol (10(-4) M) was rapidly reversed when the perfusion medium was switched to one containing atropine (10(-4) M). Bilateral atropine (10(-3) to 10(-2) M) alone did not produce any significant effects on cataplexy in narcoleptic canines; however, bilateral atropine (10(-2) M) did reduce the increase in cataplexy produced by systemic administration of physostigmine (0.05 mg/kg, i.v.). These findings demonstrate that cataplexy in narcoleptic canines can be stimulated by applying cholinergic agonists directly into the pontine reticular formation. The ability of atropine to inhibit locally and systemically stimulated cataplexy indicates that the pontine reticular formation is a critical component in cholinergic stimulation of cataplexy. Therefore, it is suggested that the pontine reticular formation plays a significant role in the cholinergic regulation of narcolepsy.
已证明,全身性给予胆碱能激动剂后,发作性睡病犬的猝倒症状会加重。此外,发作性睡病犬脑桥网状结构中的胆碱能受体数量显著增加。在本研究中,我们研究了直接向发作性睡病犬的脑桥网状结构注射胆碱能药物对猝倒的影响,猝倒定义为由情绪诱发的短暂肌张力减退发作。通过植入自由活动的发作性睡病杜宾犬和对照杜宾犬双侧脑桥网状结构的微透析探针灌注卡巴胆碱和阿托品。使用食物诱发猝倒试验对猝倒进行量化,并通过脑电图、眼电图和肌电图记录进行分析。猝倒的特征是脑电图去同步化以及肌电图和眼电图活动下降。在发作性睡病犬中,单侧和双侧卡巴胆碱(10^(-5)至10^(-3) M)均导致猝倒呈剂量依赖性增加,在最高浓度时导致完全的肌张力抑制。在对照犬中,双侧或单侧卡巴胆碱(10^(-5)至10^(-3) M)均未引发猝倒,尽管双侧卡巴胆碱在最高剂量(10^(-3))时确实导致了肌肉张力缺失。当灌注介质切换为含阿托品(10^(-4) M)的介质时,双侧卡巴胆碱(10^(-4) M)后猝倒的增加迅速逆转。单独的双侧阿托品(10^(-3)至10^(-2) M)对发作性睡病犬的猝倒没有产生任何显著影响;然而,双侧阿托品(10^(-2) M)确实减少了全身性给予毒扁豆碱(0.05 mg/kg,静脉注射)所产生的猝倒增加。这些发现表明,直接向发作性睡病犬的脑桥网状结构应用胆碱能激动剂可刺激猝倒。阿托品局部和全身性抑制猝倒的能力表明,脑桥网状结构是胆碱能刺激猝倒的关键组成部分。因此,提示脑桥网状结构在发作性睡病的胆碱能调节中起重要作用。